Juno Therapeutics

Safety concerns cloud early promise of powerful new cancer drugs
Yahoo/Reuters
Mon, 01/26/15 - 08:12 am
cancer
CAR-T
Amgen
Celgene
Bluebird Bio
Novartis
Kite Pharma
Pfizer
Cellectis
Juno Therapeutics
Kite Pharma/Amgen: A Strong Combination
Seeking Alpha
Thu, 01/15/15 - 05:50 pm
Kite Pharma
Amgen
Juno Therapeutics
Bellicum
Ziopharm
CAR-T
Biotech Investors Guide and Preview to the J.P. Morgan Healthcare Conference Part 2
TheStreet.com
Fri, 01/9/15 - 09:18 am
biotech
JPMHC 2015
Juno Therapeutics
AbbVie
MannKind
EXACT Sciences
NewLink Genetics
After CAR-T: Getting Ahead of the Next Hot Trend in Cancer Stocks
TheStreet.com
Tue, 01/6/15 - 08:56 am
CAR-T
cancer
Juno Therapeutics
Kite Pharma
Celgene
Bluebird Bio
Biotech investor explains why Juno Therapeutics won't be like Dendreon
Bizjournals.com
Fri, 01/2/15 - 07:31 pm
Juno Therapeutics
Dendreon
Health Care IPOs Remain Hot With Three New Filings
Investors.com
Wed, 12/24/14 - 08:49 am
IPOs
Intellus Medical
Althea DX
BeneChill
InfraReDx
Juno Therapeutics
devices
IPO Preview: Juno Therapeutics
Seeking Alpha
Fri, 12/19/14 - 10:31 am
IPOs
Juno Therapeutics
Blowout Year for IPOs to End with Big Biotech Offering
WSJ Online
Thu, 12/18/14 - 06:30 pm
IPOs
biotech
Bluebird Bio
Juno Therapeutics
Kite Pharma
Juno Therapeutics Sets Terms For Record Biotech IPO
Investors.com
Tue, 12/9/14 - 10:19 pm
IPOs
Juno Therapeutics
Juno takes its hot CAR-T cancer tech to Wall Street in $150M IPO
Fierce Biotech
Mon, 11/17/14 - 04:07 pm
Juno Therapeutics
CAR-T
cancer
IPOs
Juno Therapeutics Has Raised $300 Million In Just 12 Months
Forbes
Tue, 08/5/14 - 09:04 am
Juno Therapeutics
CARTs
Biotech firm takes cancer fight to startup level (video)
USA Today
Sat, 06/7/14 - 09:28 am
Juno Therapeutics
Cancer Conference Winners And Losers
Forbes
Mon, 06/2/14 - 10:38 am
ASCO
GSK
Puma Biotechnology
Merck
Roche
Bristol-Myers Squibb
Kite
Novartis
Juno Therapeutics
Eli Lilly
Clovis Oncology
AstraZeneca
Clinical Trial Of Juno Therapeutics Cell Therapy Restarts
Forbes
Sat, 04/19/14 - 10:20 am
Juno Therapeutics
Gene Therapy's Big Comeback
Forbes
Wed, 03/26/14 - 08:07 am
gene therapy
Bristol-Myers Squibb
Bluebird Bio
NightstaRx
Voyager Therapeutics
uniQure
Celladon
Juno Therapeutics
Editas Medicine
Gensight Biologics
Audentes Therapeutics
Dimension Therapeutics
Amazon's Jeff Bezos bets some of his personal cash on Juno's immunotherapy tech
Fierce Biotech
Tue, 01/14/14 - 10:00 am
Amazon
Jeff Bezos
Juno Therapeutics
immunotherapy

Pages